technetium-tc-99m-medronate and Histiocytosis--Non-Langerhans-Cell

technetium-tc-99m-medronate has been researched along with Histiocytosis--Non-Langerhans-Cell* in 1 studies

Other Studies

1 other study(ies) available for technetium-tc-99m-medronate and Histiocytosis--Non-Langerhans-Cell

ArticleYear
Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease.
    American journal of ophthalmology, 2001, Volume: 132, Issue:6

    To describe a 55-year-old male with Erdheim-Chester disease with bilateral orbital infiltration and visual loss who was successfully treated with interferon-alpha.. Interventional case report.. The patient was treated with interferon-alpha and had an improvement in his clinical signs, including his visual acuity, after 4 weeks of interferon therapy.. Interferon-alpha can be effective in the treatment of orbital infiltration secondary to Erdheim-Chester disease.

    Topics: Exophthalmos; Granuloma; Histiocytosis, Non-Langerhans-Cell; Humans; Interferon-alpha; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Diseases; Osteosclerosis; Radionuclide Imaging; Technetium Tc 99m Medronate; Visual Acuity; Xanthomatosis

2001